Elisabeth Evans

576 total citations
12 papers, 391 citations indexed

About

Elisabeth Evans is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Elisabeth Evans has authored 12 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Genetics and 6 papers in Surgery. Recurrent topics in Elisabeth Evans's work include Inflammatory Bowel Disease (8 papers), Microscopic Colitis (7 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Elisabeth Evans is often cited by papers focused on Inflammatory Bowel Disease (8 papers), Microscopic Colitis (7 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Elisabeth Evans collaborates with scholars based in United States and France. Elisabeth Evans's co-authors include William J. Sandborn, Suresh Pola, Guillaume Bouguen, Barrett G. Levesque, Richard H. Gelberman, Niels Vande Casteele, Parambir S. Dulai, Siddharth Singh, Brigid S. Boland and Nghia Nguyen and has published in prestigious journals such as Gastroenterology, Journal of Bone and Joint Surgery and Journal of Biomechanics.

In The Last Decade

Elisabeth Evans

12 papers receiving 381 citations

Peers

Elisabeth Evans
Vincent M. de Jong Netherlands
Alexandra Gutierrez United States
Cosnes France
Marilyn Pesci United States
Vincent M. de Jong Netherlands
Elisabeth Evans
Citations per year, relative to Elisabeth Evans Elisabeth Evans (= 1×) peers Vincent M. de Jong

Countries citing papers authored by Elisabeth Evans

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Evans more than expected).

Fields of papers citing papers by Elisabeth Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Evans. The network helps show where Elisabeth Evans may publish in the future.

Co-authorship network of co-authors of Elisabeth Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Evans. A scholar is included among the top collaborators of Elisabeth Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Evans. Elisabeth Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nguyen, Nghia, J. Proudfoot, Parambir S. Dulai, et al.. (2018). High body mass index is associated with increased risk of treatment failure and surgery in biologic‐treated patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics. 47(11). 1472–1479. 66 indexed citations
2.
Battat, Robert, Parambir S. Dulai, Niels Vande Casteele, et al.. (2018). Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Inflammatory Bowel Diseases. 25(2). 410–420. 30 indexed citations
3.
Boland, Brigid S., Kelly Hester, Jared Salbato, et al.. (2017). Association of Ustekinumab Concentrations Using Anser® UST Mobility Shift Assay and Clinical Response in Crohnʼs Disease. The American Journal of Gastroenterology. 112. S392–S393. 1 indexed citations
4.
Meserve, Joseph, Parambir S. Dulai, Sunhee Park, et al.. (2017). Vedolizumab does not Increase the Risk of Enteric Infections as Compared to Infliximab: A Retrospective Cohort Study. Gastroenterology. 152(5). S109–S110. 1 indexed citations
5.
Boland, Brigid S., Jesús Rivera–Nieves, Anjali Jain, et al.. (2015). 535 Soluble MAdCAM-1: A Potential Biomarker for Response to Vedolizumab. Gastroenterology. 148(4). S–106. 2 indexed citations
6.
Bouguen, Guillaume, Barrett G. Levesque, Suresh Pola, Elisabeth Evans, & William J. Sandborn. (2013). Feasibility of Endoscopic Assessment and Treating to Target to Achieve Mucosal Healing in Ulcerative Colitis. Inflammatory Bowel Diseases. 20(2). 231–239. 58 indexed citations
7.
Bouguen, Guillaume, Barrett G. Levesque, Suresh Pola, Elisabeth Evans, & William J. Sandborn. (2013). Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 12(6). 978–985. 104 indexed citations
8.
Reuther, Katherine E., Stephen J. Thomas, Elisabeth Evans, et al.. (2013). Returning to overuse activity following a supraspinatus and infraspinatus tear leads to joint damage in a rat model. Journal of Biomechanics. 46(11). 1818–1824. 10 indexed citations
9.
Bouguen, Guillaume, et al.. (2013). Feasibility of Endoscopic Assessment and Treating to Target to Achieve Mucosal Healing in Crohnʼs Disease. The American Journal of Gastroenterology. 108. S507–S507. 1 indexed citations
10.
Pola, Suresh, Sonia Ramamoorthy, Elisabeth C. McLemore, et al.. (2012). Strategies for the Care of Adults Hospitalized for Active Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 10(12). 1315–1325.e4. 46 indexed citations
11.
Pola, Suresh, et al.. (2012). Successful Use of Infliximab in the Treatment of Corticosteroid Dependent Collagenous Colitis. Inflammatory Bowel Diseases. 18. S14–S15. 1 indexed citations
12.
Gelberman, Richard H., et al.. (1980). Scaphocapitate fractures. Patterns of dislocation, mechanisms of injury, and preliminary results of treatment.. Journal of Bone and Joint Surgery. 62(2). 271–276. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026